Purdue University: Treat Cancer With Cold Plasma? Purdue Aerospace Engineer Helps Bring First Clinical Trial
August 20, 2019
August 20, 2019
WEST LAFAYETTE, Indiana, Aug. 20 [TNSmedicalresearch] -- Purdue University issued the following news release:
Cold atmospheric plasma technology, currently the only way to remove microscopic cancer tumors remaining from surgery, has been approved by the U.S. Food and Drug Administration for first-ever use in a clinical trial.
For solid tumor cancers such as those in the breast and lungs, standard treatment involves chemotherapy, radiation, surgery or all of the above. W . . .
Cold atmospheric plasma technology, currently the only way to remove microscopic cancer tumors remaining from surgery, has been approved by the U.S. Food and Drug Administration for first-ever use in a clinical trial.
For solid tumor cancers such as those in the breast and lungs, standard treatment involves chemotherapy, radiation, surgery or all of the above. W . . .